Biogen, Inc. (BIIB)
175.84
-4.60
(-2.55%)
USD |
NASDAQ |
Dec 09, 16:00
171.92
-3.92
(-2.23%)
After-Hours: 07:43
Biogen Research and Development Expense (TTM): 1.524B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Eli Lilly & Co. | 12.56B |
| Merck & Co., Inc. | 14.26B |
| Pfizer Inc. | 10.13B |
| Stoke Therapeutics, Inc. | 117.76M |